nafamostat has been researched along with Anaphylactic Reaction in 6 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat is an approved short-acting serine protease inhibitor." | 1.72 | Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration. ( Alix, M; Boehm, T; Borth, N; Gludovacz, E; Jilma, B; Petroczi, K; Salminen, TA; Vakal, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, T | 1 |
| Alix, M | 1 |
| Petroczi, K | 1 |
| Vakal, S | 1 |
| Gludovacz, E | 1 |
| Borth, N | 1 |
| Salminen, TA | 1 |
| Jilma, B | 1 |
| Ookawara, S | 1 |
| Ito, K | 1 |
| Morishita, Y | 1 |
| Sendo, T | 1 |
| Sumimura, T | 1 |
| Itoh, Y | 1 |
| Goromaru, T | 1 |
| Aki, K | 1 |
| Yano, T | 1 |
| Oike, M | 1 |
| Ito, Y | 1 |
| Mori, S | 1 |
| Nishibori, M | 1 |
| Oishi, R | 1 |
| Maruyama, H | 1 |
| Miyakawa, Y | 1 |
| Gejyo, F | 2 |
| Arakawa, M | 1 |
| Higuchi, N | 1 |
| Yamazaki, H | 1 |
| Kikuchi, H | 1 |
| Nagai, H | 1 |
| Yakuo, I | 1 |
| Inagaki, N | 1 |
| Koda, A | 1 |
| Hamano, S | 1 |
| Ujiie, A | 1 |
| Nakazawa, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)[NCT02673840] | Phase 4 | 110 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for nafamostat and Anaphylactic Reaction
| Article | Year |
|---|---|
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.
Topics: Amine Oxidase (Copper-Containing); Anaphylaxis; Benzamidines; Diminazene; Edetic Acid; Guanidines; H | 2022 |
Sustained Deterioration of Hepatic Oxygenation After Nafamostat Mesilate-Induced Anaphylactic Shock During Hemodiafiltration.
Topics: Aged; Anaphylaxis; Anticoagulants; Benzamidines; Brain; Guanidines; Hemodiafiltration; Humans; Liver | 2018 |
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
Topics: Actins; Anaphylaxis; Animals; Antigens, CD; Aorta; Benzamidines; Cadherins; Calcium Signaling; Capil | 2003 |
Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient.
Topics: Anaphylaxis; Anticoagulants; Benzamidines; Equipment Failure; Female; Guanidines; Humans; Kidney Fai | 1996 |
Anaphylactoid reaction induced by a protease inhibitor, nafamostat mesilate, following nine administrations in a hemodialysis patient.
Topics: Aged; Anaphylaxis; Benzamidines; Guanidines; Humans; Kidney Failure, Chronic; Male; Protease Inhibit | 2000 |
Role of thromboxane (Tx) A2 in guinea pig Forssman shock and the effect of OKY-046, Tx A2 synthetase inhibitor.
Topics: Acrylates; Airway Resistance; Anaphylaxis; Animals; Benzamidines; Female; Forssman Antigen; Guanidin | 1987 |